TOP
BIBLIOGRAPHY - BIBLIOGRAFIJA
Dr. Hamza Mujagić
Massachusetts
General Hospital and Harvard
University, Boston, USA
Međunarodne
knjige
1.
Mujagić H, urednik. Imunologija Univerzitet
u Tuzli, 2006. Knjiga je temeljna imunologija i u završnoj je
fazi obrade. Sudjeluju autori iz Bosne, Hrvatske, Slovenije i USA.
Poglavlja
u međunarodnim knjigama
1.
Silobrčić V, Milas L, Mujagić H. Experimental lung metastases as a
test in tumour immunology. Doll R, Vodopija I, eds. Host
environmental interactions in the ethyology of cancer in man. WHO
IARC, 1972: 411-417.
2.
Curt GA, Allegra CJ, Fine RL, Mujagić H, Yeh GC, Chabner BA. Cancer
Chemotherapy. Ulmann’s Encyclopedia of Chemistry. VCH
Verlagsgesellschaft, 1986; A5: 1-28.
3.
Supko GJ, Puchalski AT, Mujagic H,
Zhu AX, Chabner BA. Clinical Pharmacology of
Anticancer Drugs. Handin
RI, Lux SE, Stossel TP, eds. Handin’s Textbook of Hematology. Lippincott Williams &
Wilkins, 2002: 2095-2133.
4.
Mujagic Hamza: Thalidomide and its analogs. Harrisons
Textbook of Medicine, Harrisons Oncology. Lippincott
Williams and Wilkins, 2006 (in print).
5.
Mujagic Hamza: The Taxanes. Harrisons
Textbook of Medicine, Harrisons Oncology. Lippincott,
Williams and Wilkins, 2006 (in print).
Domaće
knjige
1.
Mujagić H. Praktikum iz Patološke fiziologije. Banjaluka:
Univerzitet u Banjaluci, 1987.
2.
Mujagić H. Odabrana poglavlja iz Patološke fiziologije.
Banjaluka: Univerzitet u Banjaluci, 1988.
3.
Nurkić M, Mujagić H. Imunološki riječnik. Tuzla: Univerzitet u
Tuzli, 2001.
Naučne monografije
1.
Mujagić H, Radovanović Z, Cuculić M, Vujanović N, Vujić A, Čobić P.
SSID-a, Sindrom Stečene Imunodeficitarnosti, AIDS: Svjetlost-
Sarajevo, 1988.
2.
Mujagić Hamza, Mujagić Zlata: Agresivnost tumorske bolesti.
Izdavačko
poduzeće Hamidović, Tuzla, 2003.
Znanstveni radovi
u međunarodnim časopisima
1.
Milas L, Mujagić H. Protection by Corynebacterium parvum against
tumor cells injected intravenously. Europ J Clin Biol Res 1972; 17:
498-500.
2.
Milas L, Mujagić H. The effect of splenectomy on fibrosarcoma
metastases in lungs of mice. Int J Cancer 1973; 11: 186-190.
3.
Mujagić H, Krušić J, Dešković M, Malenica B.
Immunological reactivity to non-specific antigens in cervical
carcinoma patients. Period Biol 1976; 78: 151-153.
4.
Mujagić H, Nola P, Malenica B, Maričić Ž, Allegretti N. Immunological
reactivity in colorectal carcinoma patients with special reference to
the new classification of carcinomas of colon and rectum. Period Biol
1976; 78: 153-155.
5.
Mujagić H, Mažuran R, Malenica B, Silobrčić V. Clinical detection of
cellular immunity to melanoma-specific antigens in men by the
monocyte spreading inhibition test: correlation between in vivo and
in vitro immunological test parameters. Period Biol 1976; 78:
156-157.
6.
Mažuran R, Mujagić H, Malenica B, Silobrčić V. In vitro detection of
cellular immunity to melanoma antigens in men by the monocyte
spreading inhibition test. Int J Cancer 1976; 17: 14-20.
7.
Rogan J, Mujagić H, Malenica B. Lymphocyte cytotoxicity to malignant
melanoma and cervical carcinoma cells. Period Biol 1976; 78: 155-156.
8. Malenica B, Mujagić H, Kolarić
K, Radetić M, Maričić Ž, Roguljić A, Rogan J, Vukas D. BCG
immunotherapy in metatsatic malignant melanoma. Period Biol 1976; 78:
158-159.
9.
Mujagić H.The chemotherapy of gastric carcinoma.The Medical Herald
1978;14:71-76.
10.Mujagić
H, Kolarić K, Malenica B, Nola P. BCG immunotherapy in previously
treated malignant melanoma patients. Biomedicine, 1979; 30: 95-102.
11.Mujagić H.
Immunotherapy with BCG: an attempt at standardization of methods
based on our experience and results. Period Biol 1980; 82(2):
195-205.
12.Mujagić
H, Dešković M, Malenica B, Bistrović M, Krušić J. The
significance of tuberculin immunity testing in cancer patients
(invited article). Cell Molec Biol 1980; 26: (2):111-123.
13.Mujagić H, Chen
SS, Geist R, Occhipinti SJ, Conger BM, Smith CA, Schuette WH,
Shackney SE. Effects of Vincristine on Cell Survival, Cell Cycle
Progression, and Mitotic Accumulation in asynchronously growing
Sarcoma 180 Cells. Cancer Res 1983; 43: 3591-3597.
14.Mujagić H, Conger BM, Smith CE,
Occipinti SJ, Shuette WH, Schackney SE. Schedule dependence of
Vincristine lethality in sarcoma 180 cells following partial
synchronisation with Hydroxiurea. Cancer Res 1983; 43: 3598-3603.
15.Malenica
B, Mujagić H, Popović S, Eljuga D, Allegretti N, Rogan-Grgas J.
Immunocompetence in patients with malignant melanoma. Period Biol
1983; 16: 351-353.
16.Shuette
WH, Chen SS, Occipinti SJ, Mujagić H, Shackney SE. Automated
radioautographyc grain counting: correction for grain overlap. Cell
Tissue Kinet 1983; 16: 221-227.
17.Mujagić H,
Shackney CE, Smith CE, Chen SS. Quantitative changes in surface
immunoglobulin expression in WEHI-231 lymphoma cells in relation to
their proliferative rate. Oncology, 1986; 43: 237-242.
18.Krnjajić
N, Jevrić A, Krnjajić Z, Filipović I, Mujagić, H. Comparison of PGE
and PGE2 levels in pregnant syngeneic Balb/c mice with
transplanted fibrosarcoma. Prog Clin Res 1987; 242: 119-122.
19.Mujagić H,
Krnjajić N, Jevrić A. The levels and relations of prostaglandins in
pregnant and non-pregnant tumor-bearing mice. J Cancer Res Clin Oncol
1989; 115: 383-387.
20.Mujagić H.
Aggressive chemotherapy and sensitivity persistance to anticancer
drugs.
Ann
Paul Debre Hosp 1990; 41: 7-15.
21.Mujagić H,
Mujagić Z. Detection of pleyotropic drug resistance by the rapid
immunofluorescence assay of drug effects on cell skeleton. Oncology
1991; 48(3): 202-209.
22.Mujagić H,
Blitvić A, Omeragić F. I can see you but you can not see me. Updates
1999; 1(3): 4 -11.
23. Mujagic H, Chabner BA.
Thalidomide. MD Vista J Med 2001; 4: 1-7.
24.Mujagić
H, Chabner BA, Mujagić Z. The mechanisms of action and potential
therapeutic uses of thalidomide. Croat Med J. 2002; 43(3): 274-285.
25.Mujagić
Z, Mujagić H. Circulating levels of prolactin as an indicator of
effectiveness of therapy in breast cancer patients. Int J Cancer
2002; Suppl 13: 216.
26.Mujagić Z,
Mujagić H. Prolactin–new tumor marker for breast cancer? Turk J
Biochem 2003; 28 (3): 120-121.
27.Mujagic Z, Mujagic H.
Importance of serum prolactin determinations in metastatic breast
cancer patients. Croat Med J. 2004; 45(2): 176-180.
28.Mujagic Z, Mujagic H. The
relationship of circulating prolactin levels to the size of primary
tumor in breast cancer patients. Turk J Biochem. 2004; 29 (4):
277-281.
29.Pranjic
N, Mujagic H. Gasoline sniffing and lead toxicity in workers at
gasoline stations. J Occup Env Med. 1998; 40(11): 1024-1029.
Znanstveni radovi u zbornicima
međunarodnih kongresa i simpozija
1.Mujagić H,
Kolarić K. The value of immunological skin tests in Oncology. Book of
abstracts of the Sec Int Cong Bulgarian Oncol, Varna, 1970. p.104.
2.Mažuran
R, Mujagić H, Silobrčić V. Cellular immunity in vitro to
melanoma-specific antigens in men detected by the macrophage
spreading inhibition test. Book of abstracts of the 3th Europ
Immunol Meeting, Amsterdam, 1975. p. 125.
3.Mujagić
H, Milas L, Allegretti N, Nola P, Malenica B, Maričić Ž.
Immunological reactivity in colorectal carcinoma patients with
special reference to the new T-S classification of carcinomas on the
colon and rectum. Book of abstracts of the Tenth Int Congr
Gastroenter, Budapest, 1976. p. 412.
4.Mujagić
H, Dešković M, Malenica B. Tuberculin immunity in cancer
patients; clinical and prognostic significance. Bok of abstracts of
the 12th Int Cancer Congr, Buenos Aires, 1978. p.
126.
5.Mujagić
H, Kolarić K, Nola P. Immunological status in malignant melanoma
patients. Book of abstracts of the 12th Int Cancer
Congr, Buenos Aires, 1978. p. 188.
6.Mujagić
H. Clinical immunological status in malignant melanoma patients. Book
of abstracts of the 6th Europ Immunol Meeting,
Paris, 1980. p. 188.
7.Mujagić H, Smith
CE, Shuette WH, Shackney SE. The cell tubulin content frequency
histogram obtained by flow cytometry in sarcoma 180 cells in vitro.
Proc Am Assoc Cancer Res, Denver, 1982. p. 105.
8.Chen
SS, Occipinti SJ, Mujagić H, Smith CE, Shuette WH, Shackney SE.
Multiparameter radiographic image abalysis studies in human
lymphomas. Proc Am Assoc Clin Oncol, Denver, 1982. p. 107.
9.Conger
B, Occipinti SJ, Mujagić H, Smith CE, Shuette WH, Shackney SE.
Studies on lethal and sublethal effects of Vincristine on sarcoma 180
cells in vitro. Proc Am Soc Cell Kin, Houston, 1982. p. 32.
10.Radičević
N, Mujagić H. The effect of methylnitrosourea (MNU) on the growth of
transplanted methylcholanthrene-induced fibrosarcoma in Balb/c mice.
Book of abstracts of the Second World Congress of Pharmacology,
Tokyo, 1982. p. 103.
11.Radičević
N, Mujagić H. The relationship of macrophage spreading inhibition
(MSI) with tumor growth and non-specific immunotherapy. Book of
abstracts of the 2th World Cong Pharmacol, Tokyo,
1982: Abs.10.5.56.
12.Mujagić
H. Tumor-directed immune reactivity in malignant melanoma patients.
Book of abstracts of the 2th World Congr Pharmacol,
Tokyo, 1982: Abs.10.5.51.
13.Mujagić H, Smith
CE, Occipinti S, Shuette WH, Shackney SE. The quantitative changes in
immunoglobulin contents on the surface of WEHI-231 lymphoma cells in
relation to their proliferative rate. Proc Am Assoc Cancer Res,
Atlanta, 1983. p. 32.
14.Curt GA, Bailey BD, Mujagić H,
Chabner BA. Pleiotropic drug resistance in MCF-7 human breast
carcinoma cell line. Proc Am Assoc Cancer Res, Houston, 1984. p. 104.
15.Petronijević
S, Krnjajić N, Jevrić A, Mujagić H. PGF2 alfa
levels in pregnant syngeneic Balb/c mice with transplanted
methylcholanthrene fibrosarcoma. Joint Meeting Jugosl Finish Pharm,
Dubrovnik, 1986. p. 66.
16.Krnjajić
N, Petronijević S, Jevrić A, Krnjajić Z, Mujagić H. PGFalfa and
PGF2alfa levels in pregnant syngeneic Balb/c mice with
transplanted fibrosarcoma. Book of abstracts of the 6th Conf Prostagl Rel Comp, Florence, 1986. p. 206.
17.Krnjaić
N, Jevrić A, Mujagić H, Krnjaić Z. The relationship between the
levels of PGE1 and PGE2 and
macrophage spreading inhibition in tumor bearing mice. 3th
Int Symp Prostagland, Bad Ischly, 1986. p. 17.
18.Mujagić
Z, Mujagić H. Diagnostic and Prognostic Usefulness of Prolactin (PRL)
in Breast Cancer (BC). Proc. ASCO, San Francisco, 2001. p. 20 (43b).
19.Mujagić
Z, Mujagić H. Prognostic significance of circulating levels of
prolactin (PRL) in metastatic breast cancer (MBC). Proc ASCO,
Chicago, 2003. p. 22(49).
20.Mujagic Z, Cicko E, Mujagic H.
Circulating levels of prolactin before, during and after surgery in
patients under total intravenous and general balanced anesthesia.
Proceedings of IMMPC-2, Antalya, Turkey 2004.
21.Mujagic
Z, Mujagic H. The relationship of circulating prolactin levels to the
size of primary tumor in breast cancer patients. Proceedings of the
4th European Conference: «Perspectives
in breast cancer», Madrid Spain 2004. p. 22.
Znanstveni radovi u domaćim
časopisima
1.Mujagić
H, Malenica B, Nola P, Maričić Ž, Kolarić K. BCG immunotherapy
applied after surgery in malignant melanoma patients. The Med Rev,
Galenika 1976; 16: 42-48.
2.Mujagić
H, Roth A, Smudj K, Malenica B, Juzbašić S. Immunotherapy and
chemotherapy in the treatment of advanced osteosarcoma–A case
report. Iugosl Orthopaed Acta 1977; 2: 209-213.
3.Mujagić
H. The possibilities of immunotherapy of malignant tumors in men. Med
Arch 1978; 32: 43-49.
4.Mujagić
H. The monitoring of lymphocyte blast specific and non-specific
transformation in malignant melanoma patients and the possibilities
of clinical utilisation of results. Radiol Jugosl 1978; 12: 794-804.
5.Krnjajić
N, Jevrić A, Petronijević S, Krnjajić Z, Mujagić H. PGE2
levels in pregnant syngeneic BaLb/c mice with transplanted
methylcholanthrene fibrosarcoma. Iugoslav Physiol Pharmacol Acta,
1985; 21 (3): 191-192.
6.Pertonijević
S, Krnjaić N, Jevrić A, Mujagić H. PGF2 alfa levels
in pregnant syngeneic BALB/c mice with transplanted methylcholantrene
fibrosarcoma. Iugoslav Physiol Pharmacol Acta 1985; 21(suppl.3)p. 66.
7.Mujagić
H. Morphological changes in cell skeleton caused by anticancer drugs.
Inform karcinog 1990; 7: 9-23.
8.Pjanić A, Unčanin D, Sarajlić O,
Abaspahić E, Mujagić H. Detection of cellular immunity in
gastrointestinal carcinoma patients by the leucocyte adherence
inhibition assay. Scripta Medica, 1991; 22: 10-16.
9.Šabanović
Z, Mujagić H, Bazrdjanović M. Quality of medical records as a basis
for DRG classification in the health care system in Bosnia and
Hercegovina. Med Arch 1999; 53 (suppl 3): 61-64.
10.Ljuca
Dž, Fatušić Z, Mujagić H, Ljuca F, Alispahić N. Precarcinoma
and early carcinomatous lesions in the uterine cervix and the use of
oral contraceptives. Med Arch 2000; 54 (2): 71-73.
11.Pranjić
N, Mujagić H, Nurkić M, Karamehić J, Pavlović S. Assessment of health
effects in workers at gasoline stations. Bosnian Journal of Basic
Medical Sciences 2002, 2 (1-2): 35-45.
12.Pranjić
N, Mujagić H, Pavlović S. Inhalation of gasoline and damage to health
in workers at gasoline stations. Med Arch 2003; 57 (1): 17-20.
13.Mujagić
H, Prnjavorac B, Mujagić Z, Festa G. Alcohol in alcoholic liver
disease is a causative factor for development of allergic skin
manifestations. Med Arch 2003; 57 (5-6): 273-278.
14.Mujagić
Z, Mujagić H. Diagnostic usefulness of serum carcinoembryonic antigen
determinations in breast cancer patients. Bosnian Journal of Basic
Medical Sciences 2003; 3 (2): 30-34.
15.Mujagić Z,
Mujagić H, Prnjavorac B. Circulating levels of prolactin in breast
cancer patients. Med Arch 2005;59 (1):33-35.
16.Mujagić
Z, Mujagić H, Prnjavorac B. The relationship between carcinoembryonic
antigen (CEA) levels and parameters of primary tumor and metastases
in breast cancer patients. Med Arch 2004;58 (1): 23-26.
17.Mujagić Z,
Mujagić H, Prnjavorac B. The relationship between circulating
carcinoembryonic antigen (CEA) levels and parameters of primary tumor
and metastases in breast cancer patients. Med Arch 2004; 58 (1):
23-26
Znanstveni
radovi u zbornicima domaćih kongresa i simpozija
1.Mujagić
H, Milas L. The effect of Corynebacterium parvum on the growth of
experimental metastases of fibrosarcoma in the lungs of C57BL
mice. Proc Jugosl Immunol Soc, Beograd 1971. p. 68.
2.
Milas L, Mujagić H. The growth of experimental metastases of
fibrosarcoma in the lungs of splenectomised C57BL mice. Proc Jugosl
Immunol Soc, Beograd 1971. p. 67.
3.Mujagić
H, Milas L, Malenica B, Jurčić D, Krušić J. Immunological
reactivity in patients with rectal carcinoma. Book of abstracts of
the Sixth Congr Jugosl Oncol, Sarajevo, 1975. p. 77.
4.Malenica B, Mujagić H, Radetić M, Maričić Ž, Roguljić A, Vukas D. BCG immunostimulation in malignant metastatic
melanoma patients. Book of abstracts of the Sixth Congr Jugosl Oncol, Sarajevo, 1975. p. 30.
5.Mujagić H, Krušić J, Dešković M, Malenica B.
Imunološka reaktivnost nespecifične antigene u bolesnica s karcinomom cerviksa.
Book of abstracts of the Sixth Congr Jugosl Oncol,Sarajevo, 1975: 35.
6.Mujagić H, Mažuran R, Malenica
B, Silobrčić V. Klinička detekcija celularne imunosti na melanomske
antigene in vitro testom inhibicije širenja monocita. Book of
abstracts of the Sixth Congr Jugosl Oncol, Sarajevo, 1975. p. 36.
7.Rogan J, Mujagić H, Malenica B. Citotoksičnost limfocita bolesnika s melanomom. Book
of abstracts of the Sixth Congr Jugosl Oncol, Sarajevo, 1975. p. 49.
8.Mujagić H, Kolarić K, Malenica B, Popović Š, Maričić Ž. BCG-imunostimulacija bolesnika s malignim melanomom. Book
of abstracts of the Sixth Congr Jugosl Oncol, Sarajevo, 1975. p. 80.
9.Mujagić H, Djordjević J, Lovrinčević A, Starović B. The extent of disease and
frequency of localisation of metastases in malignant melanoma
patients. Book of Abstracts of the Int Jugosl Radiol Congr, Novi Sad,
1980. p. 39.
10.Mujagić
H, Malenica B, Nola P. Immunological Prophyle in malignant melanoma
patients. Book of abstracts of the Sixth Int Cong Iugosl Oncol,
Ljubljana, 1980. p.43.
11.Hadžiomerović V, Mujagić H, Bušić I. Immunological characteristics of
patients with carcinomas of the head and neck. Book of abstracts of the Sec Int Congr ENT Soc,
Niš, 1980. p. 21.
12. Hadžiomerović V, Mujagić H.
The combination of Doxorubicin and radiotherapy in the treatment of
patients with carcinoma of head and neck. Book of abstracts of the
Sixth Int Congr Yugosl Oncol, Ljubljana, 1980. p. 44.
13.
Krnjajić A, Jevrić A, Petronijević S, Mujagić H, Krnjajić Z. PGE2
levels in pregnant BaLb/c mice with transplanted methylcholanthrene
Fibrosarcoma. Book of abstracts of the Ninth Congr Yugosl Pharm Soc,
Beograd, 1985: p. 193.
14.Krnjaić
N, Jevrić A, Mujagić H, Petronijević S, Krnjaić Z. PGE1
levels in pregnant syngeneic BALB/c mice with transplanted
methylcholantrene fibrosarcoma. Book of abstracts of the 13th
Congress of UYPS, Skopje, 1985: Abs. 291.
15.Mujagić
H. Liječenje bolesnika sa malignim tumorom u uvjetima promijenjene
ekološke sredine. Zbornik radova Simpozija o životnoj sredini,
Novi Sad, 1990. p. 17.
16.Mujagić Z,
Mujagić H. The relationship between smoking habits and serum
prolactin levels in breast cancer patients. Proceedings of the First
Bosnia and Herzegovina Congress of Occupational Medicine with
International Participations, Tuzla, 2003. p. 242.
17.Mujagić Z, Mujagić H.
Circulating levels of prolactin in relation to age in breast cancer
patients. Proceedings of the First Bosnia and Herzegovina Congress of
Occupational Medicine with International Participations, Tuzla, 2003.
p. 256.
Prof.
Dr. med. Sc., Hamza Mujagic
Massachusetts
General Hospital and Harvard
University, Boston, USA
BIOGRAPHY
-
BIOGRAFIJA
Powered by
ORBUS Belgium
